Mark D Nellermoe Professional Service Corporation Podiatrist Medicare: Medicare Enrolled Practice Location: 3929 Bridgeport Way W Ste 308, University Place, WA 98466 Phone: 253-627-4181 Fax: 253-272-5922 |
Dr. Cynthia A Fenberg, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 5225 Cirque Dr W, Suite 100, University Place, WA 98467 Phone: 253-474-4353 Fax: 253-474-5850 |
Cynthia A Fenberg Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 5225 Cirque Dr W, Ste 100, University Place, WA 98467 Phone: 253-474-4353 Fax: 253-474-5850 |
Dr. Mark Dale Nellermoe, D.P.M. Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 3929 Bridgeport Way W Ste 308, University Place, WA 98466 Phone: 253-627-4181 Fax: 253-272-5922 |
Caleb Paul Thomas, DPM Podiatrist - Foot Surgery Medicare: Medicare Enrolled Practice Location: 3929 Bridgeport Way W Ste 308, University Place, WA 98466 Phone: 253-272-2999 Fax: 253-272-4699 |
Dr. Thomas Matthew Burghardt, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3929 Bridgeport Way W Ste 308, University Place, WA 98466 Phone: 253-272-2999 Fax: 253-272-4699 |
News Archive
Today, nearly 700,000 people in the U.S. are living with a brain tumor, and yet, when it comes to pinpointing causes or risk factors, scientists are still searching for answers.
A nationwide effort to coordinate mental health with primary care is underway, The Philadelphia Inquirer reports. "The idea is to give simple interventions in 15- to 30-minute visits that will address behavioral issues ranging from stress to traumatic reactions that often go untreated." Some clinics have coupled licensed social workers with their other clinical staff; the mental health experts provide services while patients and family members receive physical care.
NovaDel Pharma Inc. announced that an article titled "Rapid Oral Transmucosal Absorption of Sumatriptan, and Pharmacodynamics in Acute Migraine" was published online on June 22, 2009 in the peer-reviewed journal Headache: The Journal of Head and Face Pain.
The New York Times: Johnson & Johnson has said it will "revamp its quality controls, creating a single framework for its drug, medical device and consumer health care divisions." The move comes after the drugmaker saw a number of recalls of its medicines, such as Tylenol and Motrin, as well as probes by a congressional committee and the FDA into actions at its McNeil Consumer Healthcare subsidiary.
Among many breakthroughs that have made living longer possible, better health care-and more experts to make that care possible-loom large.
› Verified 8 days ago